Perspective on measurable residual disease testing in acute myeloid leukemia. Walter RB. Leukemia 2023 Nov 16. doi: 10.1038/s41375-023-02084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Walter RB. Perspective on measurable residual disease testing in acute myeloid leukemia. Leukemia 2023 Nov 16. doi: 10.1038/s41375-023-02084.
PMID: 37973819